- Home
- STIM vs WLAC Comparison
STIM vs WLAC Comparison
Compare STIM & WLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- WLAC
- Stock Information
- Founded
- STIM 2003
- WLAC 2024
- Country
- STIM United States
- WLAC United States
- Employees
- STIM N/A
- WLAC N/A
- Industry
- STIM Medical/Dental Instruments
- WLAC
- Sector
- STIM Health Care
- WLAC
- Exchange
- STIM Nasdaq
- WLAC Nasdaq
- Market Cap
- STIM 192.0M
- WLAC 171.5M
- IPO Year
- STIM 2018
- WLAC 2024
- Fundamental
- Price
- STIM $4.13
- WLAC $9.96
- Analyst Decision
- STIM Buy
- WLAC
- Analyst Count
- STIM 4
- WLAC 0
- Target Price
- STIM $4.67
- WLAC N/A
- AVG Volume (30 Days)
- STIM 2.1M
- WLAC 9.5K
- Earning Date
- STIM 03-04-2025
- WLAC 01-01-0001
- Dividend Yield
- STIM N/A
- WLAC N/A
- EPS Growth
- STIM N/A
- WLAC N/A
- EPS
- STIM N/A
- WLAC N/A
- Revenue
- STIM $72,711,000.00
- WLAC N/A
- Revenue This Year
- STIM $3.23
- WLAC N/A
- Revenue Next Year
- STIM $29.55
- WLAC N/A
- P/E Ratio
- STIM N/A
- WLAC N/A
- Revenue Growth
- STIM 5.03
- WLAC N/A
- 52 Week Low
- STIM $0.52
- WLAC $9.95
- 52 Week High
- STIM $5.07
- WLAC $10.50
- Technical
- Relative Strength Index (RSI)
- STIM 59.06
- WLAC N/A
- Support Level
- STIM $2.80
- WLAC N/A
- Resistance Level
- STIM $5.03
- WLAC N/A
- Average True Range (ATR)
- STIM 0.49
- WLAC 0.00
- MACD
- STIM 0.04
- WLAC 0.00
- Stochastic Oscillator
- STIM 59.64
- WLAC 0.00
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares
Willow Lane Acquisition Corp is a blank check company.